US Stock MarketDetailed Quotes
RNLXY Renalytix
- 0.147
- -0.001-0.93%
15min DelayTrading Nov 13 13:43 ET
24.59MMarket Cap-237P/E (TTM)
0.151High0.139Low148.47KVolume0.141Open0.149Pre Close21.41KTurnover0.10%Turnover RatioLossP/E (Static)166.82MShares2.40052wk High-3.14P/B21.56MFloat Cap0.12052wk Low--Dividend TTM146.24MShs Float35.710Historical High--Div YieldTTM7.79%Amplitude0.120Historical Low0.144Avg Price1Lot Size
About Renalytix Company
Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in Penarth, the United Kingdom.
Company Profile
SymbolRNLXY
Company NameRenalytix
Founded2018
CEOMr. James Renwick McCullough
MarketPink Market
Employees93
Securities TypeDR
ADS Ratio1.0 : 20.0
Fiscal Year Ends06-30
AddressAvon House,19 Stanwell Road
CityPenarth
ProvinceCardiff
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeCF64 2EZ
Phone44-20-3139-2910
Websitehttps://renalytixai.com/
Company Executives
- Name
- Position
- Salary
- James Renwick McCullough
- Executive Director,Chief Executive Officer
- 780.11K
- Fergus Fleming
- Executive Director,Chief Technical Officer
- 425.70K
- Julian Huw Baines MBE
- Executive Director,Chairman
- --
- Christopher Harwood Bernard Mills
- Non-Executive Director
- --
- Dr. Erik Lium, PhD
- Non-Executive Director
- 204.50K
- Catherine Havlik Coste, C.P.A.
- Non-Executive Director
- 353.15K
- Salim Hamir
- Company Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data